ALS Therapy Development Institute and Aestus Therapeutics, Inc. Collaborate to Investigate Potential Treatments for ALS

The ALS Therapy Development Institute (ALS TDI) and Aestus Therapeutics, Inc., announced their plans today to test several potential small-molecule compounds to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS, Lou Gehrig’s disease).

Click here to read more.

Share this: